NASWALL

This brand name is authorized in Hong Kong

Active ingredients

The drug NASWALL contains one active pharmaceutical ingredient (API):

1 Nifuroxazide UNII PM5LI0P38J - NIFUROXAZIDE
Nifuroxazide is a member of benzoic acids. Nifuroxazide is often used as an anti-diarrhoeal medicine. Read about Nifuroxazide

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
A07AX03	Nifuroxazide	A Alimentary tract and metabolism → A07 Antidiarrheals, intestinal antiinflammatory/antiinfective agents → A07A Intestinal antiinfectives → A07AX Other intestinal antiinfectives
Discover more medicines within A07AX03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: HK	Department of Health Drug Office	Identifier(s): 54739

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.